Cargando…

A Bayesian adaptive design for biomarker trials with linked treatments

BACKGROUND: Response to treatments is highly heterogeneous in cancer. Increased availability of biomarkers and targeted treatments has led to the need for trial designs that efficiently test new treatments in biomarker-stratified patient subgroups. METHODS: We propose a novel Bayesian adaptive rando...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wason, James M S, Abraham, Jean E, Baird, Richard D, Gournaris, Ioannis, Vallier, Anne-Laure, Brenton, James D, Earl, Helena M, Mander, Adrian P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559835/ https://www.ncbi.nlm.nih.gov/pubmed/26263479 http://dx.doi.org/10.1038/bjc.2015.278

Ejemplares similares

An adaptive trial design for updating the threshold of a continuous biomarker
por: Spencer, Amy, et al.
Publicado: (2015)

An adaptive design for updating the threshold value of a continuous biomarker
por: Spencer, Amy V., et al.
Publicado: (2016)

A comparison of bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2013)

Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features
por: Grayling, Michael J., et al.
Publicado: (2017)

An adaptive biomarker strategy clinical trial design
por: Wason, James, et al.
Publicado: (2013)

Admissible multiarm stepped‐wedge cluster randomized trial designs
por: Grayling, Michael J., et al.
Publicado: (2018)

An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)

Group sequential crossover trial designs with strong control of the familywise error rate
por: Grayling, Michael J., et al.
Publicado: (2018)

Exact group sequential designs for two-arm experiments with Poisson distributed outcome variables
por: Grayling, Michael J., et al.
Publicado: (2021)

Optimal multistage designs for randomised clinical trials with continuous outcomes
por: Wason, James MS, et al.
Publicado: (2012)

Group sequential designs for stepped-wedge cluster randomised trials
por: Grayling, Michael J, et al.
Publicado: (2017)

Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
por: Wason, James M. S., et al.
Publicado: (2012)

Adaptive enrichment in biomarker-stratified clinical trial design
por: Parashar, Deepak, et al.
Publicado: (2013)

Bayesian design and analysis of external pilot trials for complex interventions
por: Wilson, Duncan T., et al.
Publicado: (2021)

Stepped-wedge cluster randomised trials: where, when and why?
por: Grayling, Michael, et al.
Publicado: (2015)

The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected
por: Wason, James MS, et al.
Publicado: (2015)

When to keep it simple – adaptive designs are not always useful
por: Wason, James M. S., et al.
Publicado: (2019)

Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
por: Wason, James M S, et al.
Publicado: (2014)

Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
por: Grayling, Michael J., et al.
Publicado: (2018)

Blinded and unblinded sample size reestimation in crossover trials balanced for period
por: Grayling, Michael J., et al.
Publicado: (2018)

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies
por: Wason, J, et al.
Publicado: (2014)

Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes – what does it all mean?
por: Earl, Helena, et al.
Publicado: (2015)

Adaptive designs in clinical trials: why use them, and how to run and report them
por: Pallmann, Philip, et al.
Publicado: (2018)

The Bayesian Design of Adaptive Clinical Trials
por: Giovagnoli, Alessandra
Publicado: (2021)

The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
por: Dimairo, Munyaradzi, et al.
Publicado: (2020)

The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
por: Dimairo, Munyaradzi, et al.
Publicado: (2020)

Bayesian modelling strategies for borrowing of information in randomised basket trials
por: Ouma, Luke O., et al.
Publicado: (2022)

Response‐adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?
por: Villar, Sofía S., et al.
Publicado: (2017)

Simulation work in adaptive dose-finding designs to identify dose-intervals that achieve targets in multiple endpoints
por: Howlett, James, et al.
Publicado: (2015)

Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs
por: Wang, Yu, et al.
Publicado: (2022)

SSNdesign—An R package for pseudo-Bayesian optimal and adaptive sampling designs on stream networks
por: Pearse, Alan R., et al.
Publicado: (2020)

A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials
por: Kunzmann, Kevin, et al.
Publicado: (2021)

Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
por: Dimairo, Munyaradzi, et al.
Publicado: (2018)

Application of Bayesian analysis to the doubly labelled water method for total energy expenditure in humans
por: Ruan, Yue, et al.
Publicado: (2017)

Bayesian adaptive clinical trial designs for respiratory medicine
por: Ryan, Elizabeth G., et al.
Publicado: (2022)

Bayesian association scan reveals loci associated with human lifespan and linked biomarkers
por: McDaid, Aaron F., et al.
Publicado: (2017)

Patient drift and response-adaptive randomisation: impact and solutions
por: Villar, Sofia S, et al.
Publicado: (2015)

Bayesian mechanism design
por: Hartline, Jason D
Publicado: (2013)

Subgroup identification for treatment selection in biomarker adaptive design
por: Lu, Tzu-Pin, et al.
Publicado: (2015)

Response adaptive intervention allocation in stepped‐wedge cluster randomized trials
por: Grayling, Michael J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_us06tca6b67ud766t3hb2ck5l1